Dose Range Finding Trial for Tozorakimab in Adults With Uncontrolled Asthma
Phase 2
540
about 3 years
18–75
51 sites in CA, DE, FL +22
What this study is about
This trial is testing different doses of tozorakimab, a medication given by injection, in adults with uncontrolled asthma who are already taking medium-to-high doses of inhaled corticosteroids. The goal is to see if these doses are effective and safe.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take Tozorakimab
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
monoclonal antibody
Secondary: Change from baseline in post-bronchodilator FEV1, Change from baseline in pre-bronchodilator forced expiratory volume in 1 second (FEV1), Change from baseline in the Asthma Control Questionnaire 6 (ACQ-6), Change from baseline in the Asthma Quality of Life Questionnaire for 12 Years and Older (AQLQ12+)
Respiratory